000143926 001__ 143926
000143926 005__ 20240229123017.0
000143926 0247_ $$2doi$$a10.1002/ijc.32486
000143926 0247_ $$2pmid$$apmid:31162856
000143926 0247_ $$2ISSN$$a0020-7136
000143926 0247_ $$2ISSN$$a1097-0215
000143926 0247_ $$2altmetric$$aaltmetric:61601284
000143926 037__ $$aDKFZ-2019-01484
000143926 041__ $$aeng
000143926 082__ $$a610
000143926 1001_ $$0P:(DE-He78)1573258b58c33f1922ca9719d0c8c4ab$$aBecker, Nikolaus$$b0$$eFirst author$$udkfz
000143926 245__ $$aLung cancer mortality reduction by LDCT screening - results from the randomised German LUSI trial.
000143926 260__ $$aBognor Regis$$bWiley-Liss$$c2020
000143926 3367_ $$2DRIVER$$aarticle
000143926 3367_ $$2DataCite$$aOutput Types/Journal article
000143926 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1601381501_26602
000143926 3367_ $$2BibTeX$$aARTICLE
000143926 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000143926 3367_ $$00$$2EndNote$$aJournal Article
000143926 500__ $$a2020 Mar 15;146(6):1503-1513 #EA:C020#LA:E010#
000143926 520__ $$aIn 2011, the US National Lung Cancer Screening Trial (NLST) reported a 20% reduction of lung cancer mortality after regular screening by low-dose computed tomography (LDCT), as compared to X-ray screening. The introduction of lung cancer screening programs in Europe awaits confirmation of these first findings from European trials that started in parallel with the NLST. The German Lung cancer Screening Intervention ('LUSI') is a randomized trial among 4,052 long-term smokers, 50-69 years of age, recruited from the general population, comparing 5 annual rounds of LDCT screening (screening arm; n=2,029 participants) with a control arm (n=2,023) followed by annual postal questionnaire inquiries. Data on lung cancer incidence and mortality and vital status were collected from hospitals or office-based physicians, cancer registries, population registers and health offices. Over an average observation time of 8.8 years after randomization, the hazard ratio for lung cancer mortality was 0.74 [95%CI: 0.46 - 1.19; p=0.21] among men and women combined. Modelling by sex, however showed a statistically significant reduction in lung cancer mortality among women (HR=0.31 [95%CI: 0.10 - 0.96], p=0.04), but not among men (HR=0.94 [95%CI: 0.54 - 1.61], p=0.81) screened by LDCT (pheterogeneity = 0.09). Findings from LUSI are in line with those from other trials, including NLST, that suggest a stronger reduction of lung cancer mortality after LDCT screening among women as compared to men. This heterogeneity could be the result of different relative counts of lung tumor sub-types occurring in men and women. This article is protected by copyright. All rights reserved.
000143926 536__ $$0G:(DE-HGF)POF3-315$$a315 - Imaging and radiooncology (POF3-315)$$cPOF3-315$$fPOF III$$x0
000143926 588__ $$aDataset connected to CrossRef, PubMed,
000143926 7001_ $$0P:(DE-He78)474d6825dc4c767e7164354e6fe8c885$$aMotsch, Erna$$b1$$udkfz
000143926 7001_ $$0P:(DE-He78)8597d05ee46a87bec084908e653c08ef$$aTrotter, Anke$$b2$$udkfz
000143926 7001_ $$aHeussel, Claus P$$b3
000143926 7001_ $$aDienemann, Hendrik$$b4
000143926 7001_ $$aSchnabel, Philipp A$$b5
000143926 7001_ $$aKauczor, Hans-Ulrich$$b6
000143926 7001_ $$0P:(DE-HGF)0$$aGonzález Maldonado, Sandra$$b7
000143926 7001_ $$aMiller, Anthony B$$b8
000143926 7001_ $$0P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a$$aKaaks, Rudolf$$b9$$udkfz
000143926 7001_ $$0P:(DE-He78)3e76653311420a51a5faeb80363bd73e$$aDelorme, Stefan$$b10$$eLast author$$udkfz
000143926 773__ $$0PERI:(DE-600)1474822-8$$a10.1002/ijc.32486$$gp. ijc.32486$$n6$$p1503-1513$$tInternational journal of cancer$$v146$$x1097-0215$$y2020
000143926 909CO $$ooai:inrepo02.dkfz.de:143926$$pVDB
000143926 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)1573258b58c33f1922ca9719d0c8c4ab$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000143926 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)474d6825dc4c767e7164354e6fe8c885$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000143926 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)8597d05ee46a87bec084908e653c08ef$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000143926 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000143926 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a$$aDeutsches Krebsforschungszentrum$$b9$$kDKFZ
000143926 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)3e76653311420a51a5faeb80363bd73e$$aDeutsches Krebsforschungszentrum$$b10$$kDKFZ
000143926 9131_ $$0G:(DE-HGF)POF3-315$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vImaging and radiooncology$$x0
000143926 9141_ $$y2020
000143926 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000143926 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000143926 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000143926 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000143926 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bINT J CANCER : 2017
000143926 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000143926 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000143926 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000143926 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000143926 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000143926 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000143926 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bINT J CANCER : 2017
000143926 9202_ $$0I:(DE-He78)E010-20160331$$kE010$$lE010 Radiologie$$x0
000143926 9200_ $$0I:(DE-He78)C130-20160331$$kC130$$lPersonalisierte Früherkennung des Prostatakarzinoms$$x0
000143926 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000143926 9201_ $$0I:(DE-He78)E010-20160331$$kE010$$lE010 Radiologie$$x1
000143926 980__ $$ajournal
000143926 980__ $$aVDB
000143926 980__ $$aI:(DE-He78)C020-20160331
000143926 980__ $$aI:(DE-He78)E010-20160331
000143926 980__ $$aUNRESTRICTED